Zevtera ceftobiprole medocaril regulatory update

FDA granted Qualified Infectious Disease Product (QIDP) designation to Zevtera ceftobiprole medocaril from Basilea to treat community-acquired bacterial pneumonia (CABP) and acute bacterial skin and s...